Skip to main content
Live · TradingView
Back to the NewsWire

Fiercepharma

Published September 9, 2026 · Updated September 10, 2026

FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits

Read the full story at Fiercepharma

A psychiatrist and pharmacologist by training, he was also formerly the chief medical officer at non-profit psychedelic drug developer Usona Institute.

Surfaced by this Google Alert

  • Psychedelic biotech